2022 ICD-10-CM Code C46.4
Kaposi's sarcoma of gastrointestinal sites
Valid for Submission
| ICD-10: | C46.4 |
| Short Description: | Kaposi's sarcoma of gastrointestinal sites |
| Long Description: | Kaposi's sarcoma of gastrointestinal sites |
Code Classification
C46.4 is a billable diagnosis code used to specify a medical diagnosis of kaposi's sarcoma of gastrointestinal sites. The code C46.4 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code C46.4 might also be used to specify conditions or terms like kaposi's sarcoma of gastrointestinal tract.
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C46.4 are found in the index:
- - Kaposi's
- - sarcoma
- - colon - C46.4
- - gastrointestinal organ - C46.4
- - rectum - C46.4
- - stomach - C46.4
- - sarcoma
- - Sarcoma (of) - See Also: Neoplasm, connective tissue, malignant;
- - Kaposi's
- - colon - C46.4
- - gastrointestinal organ - C46.4
- - rectum - C46.4
- - stomach - C46.4
- - Kaposi's
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Kaposi's sarcoma of gastrointestinal tract
Diagnostic Related Groups - MS-DRG Mapping
The ICD-10 code C46.4 is grouped in the following groups for version MS-DRG V39.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2021 through 09/30/2022.
| MS-DRG | MS-DRG Title | MCD | Relative Weight |
|---|---|---|---|
| 374 | DIGESTIVE MALIGNANCY WITH MCC | 06 | 2.0679 |
| 375 | DIGESTIVE MALIGNANCY WITH CC | 06 | 1.2049 |
| 376 | DIGESTIVE MALIGNANCY WITHOUT CC/MCC | 06 | 0.8952 |
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert C46.4 to ICD-9 Code
- 176.3 - GI sites - kpsi's srcoma
Information for Patients
Kaposi Sarcoma
Kaposi sarcoma (KS) is a cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat, in lymph nodes, or in other organs. These patches, or lesions, are usually red or purple. They are made of cancer cells, blood vessels, and blood cells.
KS is caused by infection with human herpesvirus-8 (HHV-8). Most people infected with HHV-8 don't get KS. It usually happens in
- People with weak immune systems, due to HIV/AIDS, drugs taken after an organ transplant, or another disease
- Older men of Jewish or Mediterranean descent
- Young men in Africa
The skin lesions may not cause symptoms. But they can spread to other parts of the body, especially in people with HIV/AIDS. If they spread to the digestive tract or lungs, they can cause bleeding. Lesions on the lungs can also make it hard to breathe.
Treatment depends on where the lesions are and how bad they are. Options include radiation therapy, surgery, chemotherapy, and biologic therapy. People with HIV/AIDS also take HIV/AIDS medicines.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)